Photon vs proton radiation for early tonsil cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial compares two types of radiation—photon therapy and proton therapy—for early-stage tonsil cancer. The goal is to see which approach works well for cure while affecting surrounding tissues differently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been newly diagnosed with tonsil squamous cell cancer that is stage early (T1–2), spread to none or limited lymph nodes, and has not been treated before.
- Your cancer plan is mainly one-sided (same side) radiation with curative intent, and any surgery (if needed) is only for rescue, not planned as the main treatment.
- You are well enough to do daily activities (performance status 0–1).
- You can understand the study and agree by signing written consent.
- Your doctors do not expect you to need both sides radiation or chemotherapy for your situation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tries to see if less intense radiation can still work well for certain throat cancers linked to HPV. It is looking for people with early stage HPV-positive oropharynx cancer who may benefit from a lighter treatment plan.
This study compares ways of treating early squamous cell cancer in the tonsil or the tongue base, using either radiation therapy, transoral (through-the-mouth) surgery, or both. It aims to see which approach works best while keeping cancer under control.
This trial compares two types of radiation therapy for head and neck cancer: proton therapy (a newer, more targeted approach) versus standard photon therapy (the current common treatment). The goal is to see if protons reduce side effects while treating the cancer just as well.
This trial tests whether using a detailed scan (SPECT) to guide radiation therapy to only one side of the neck works as well as treating both sides. It is for people with oropharyngeal (tonsil, soft palate, or tongue base) cancer that has not spread to the opposite side of the neck.
This trial compares proton therapy and standard photon therapy given before surgery for esophageal (or stomach–esophagus) cancer. It aims to see which radiation approach works better and is safer as part of a combined treatment plan.
This trial tests a combination of two targeted drugs (nimotuzumab and toripalimab) with chemotherapy for people with advanced tonsil cancer that can be surgically removed. The goal is to see if this approach works better than standard treatment.
Hear when a new Tonsil Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.